Letter received from patient, (b)(6) alleging multiple problems after application of gluma.Letter described many symptoms and ailments, including hot/cold sensitivity, tingling, itching, loss of appetite and weight loss, darkened and dry skin.Also included with the letter was a 1996 msds for gluma desensitizer, given to patient by her dds.After extraction of the tooth that was sensitive, her symptoms reportedly improved but did not dissipate entirely.This incident is reportable according to 21 cfr 803.The fda defines this as a serious injury (21 cfr sec.803.3) as the patient reported having an adverse reaction.Because the malfunction allegation could not be confirmed, the cause of the adverse reaction could not be determined.The incident will be reported to maintain compliance with 21 cfr 803 and out of an abundance of caution.
|
This incident is reportable according to 21 cfr 803.The fda defines this as a serious injury (21 cfr sec.803.3) as the patient reported having an adverse reaction.Because the malfunction allegation could not be confirmed, the cause of the adverse reaction could not be determined.(b)(4).Although we have not established that the device caused or contributed to the event, we're reporting it to be compliant with 21 cfr part 803 and out of an abundance of caution.The product was not returned nor evaluated.The lot number(s) were not provided.
|